Biohaven (BHVN) Cash from Operations (2021 - 2026)
Biohaven (BHVN) reported Cash from Operations of 149918000.0 for Q1 2026, up 9.21% on a YoY basis from 137276436.71 in Q1 2025, and down 14.74% sequentially from 130662000.0 in Q4 2025.
Biohaven (BHVN) Cash from Operations (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Cash from Operations data on file, last reported at 149918000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 9.21% year-over-year to 149918000.0; the trailing twelve-month figure through Mar 2026 stood at 594232000.0 (up 7.86% YoY), and the FY2025 full-year result was 609438000.0, down 4.63% from the prior year.
- Cash from Operations slipped to 149918000.0 in Q1 2026, from 130662000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 44393000.0 in Q2 2023 to a low of 170742000.0 in Q4 2024.
- A 5-year average of 115954294.12 and a median of 114881000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 34.61% in 2023 and plunged 277.98% in 2024, its largest moves.
- Tracing BHVN's Cash from Operations over 5 years: stood at 75407000.0 in 2022, then slumped by 52.35% to 114881000.0 in 2023, then slumped by 48.63% to 170742000.0 in 2024, then rose by 23.47% to 130662000.0 in 2025, then slipped by 14.74% to 149918000.0 in 2026.
- Business Quant data shows BHVN's Cash from Operations at 149918000.0 in Q1 2026, 130662000.0 in Q4 2025, and 145716000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -149.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149.92 Mn |
| Mar 31, 2026 | -149.92 Mn |
| Dec 31, 2025 | -130.66 Mn |
| Dec 31, 2025 | -130.66 Mn |
| Sep 30, 2025 | -145.72 Mn |
| Sep 30, 2025 | -145.72 Mn |
| Jun 30, 2025 | -167.94 Mn |
| Jun 30, 2025 | -167.94 Mn |
| Mar 31, 2025 | -165.12 Mn |
| Mar 31, 2025 | -165.12 Mn |
| Dec 31, 2024 | -170.74 Mn |
| Dec 31, 2024 | -170.74 Mn |
| Sep 30, 2024 | -141.28 Mn |
| Sep 30, 2024 | -141.28 Mn |
| Jun 30, 2024 | -167.80 Mn |
| Jun 30, 2024 | -167.80 Mn |
| Mar 31, 2024 | -102.64 Mn |
| Mar 31, 2024 | -102.64 Mn |
| Dec 31, 2023 | -114.88 Mn |
| Dec 31, 2023 | -114.88 Mn |